Related Experiment Video
Updated: Aug 11, 2025

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Impaired calcium handling mechanisms in atrial trabeculae of diabetic patients
Timothy L M Jones1, Sarbjot Kaur1, Nicholas Kang2
1Department of Physiology, University of Auckland, Auckland, New Zealand.
Insights
Diabetic patients show impaired cardiomyocyte calcium handling and contractile dysfunction in atrial tissue. This dysfunction involves altered calcium transients and reduced myofilament calcium sensitivity, impacting heart function.
Area of Science:
- Cardiology
- Physiology
- Biochemistry
Background:
- Type 2 diabetes is associated with cardiovascular complications.
- Diabetic cardiomyopathy affects cardiac structure and function.
- Alterations in cardiomyocyte calcium handling are implicated in diabetic heart disease.
Purpose of the Study:
- To investigate cardiomyocyte calcium (Ca2+) handling and contractile function in human atrial tissue from diabetic and non-diabetic patients.
- To compare Ca2+ transients, myofilament Ca2+ sensitivity, and developed force between groups.
- To elucidate the impact of diabetes on atrial electro-mechanical coupling.
Main Methods:
- Dissection of multicellular atrial trabeculae from diabetic and non-diabetic patients.
- Measurement of intracellular Ca2+ using fura-2/AM during electrical stimulation.
- Assessment of myofilament Ca2+ sensitivity via phase plots and high potassium contractures.
Main Results:
- Diabetic trabeculae exhibited increased diastolic Ca2+ and reduced Ca2+ transient amplitude.
- Peak developed stress was decreased, and diastolic stress was increased in diabetic trabeculae.
- Myofilament Ca2+ sensitivity was diminished in atrial tissue from diabetic patients.
Conclusions:
- Diabetes impairs cardiomyocyte Ca2+ handling and leads to contractile dysfunction in human atrial tissue.
- Altered Ca2+ homeostasis and reduced myofilament Ca2+ sensitivity contribute to diabetic cardiomyopathy.
- Targeting cardiomyocyte Ca2+ handling may offer future therapeutic strategies for diabetic heart disease.
Abstract:
The aim of this study was to investigate cardiomyocyte Ca2+ handling and contractile function in freshly excised human atrial tissue from diabetic and non-diabetic patients undergoing routine surgery. Multicellular trabeculae (283 ± 20 μm in diameter) were dissected from the endocardial surface of freshly obtained right atrial appendage samples from consenting surgical patients. Trabeculae were mounted in a force transducer at optimal length, electrically stimulated to contract, and loaded with fura-2/AM for intracellular Ca2+ measurements. The response to stimulation frequencies encompassing the physiological range was recorded at 37°C. Myofilament Ca2+ sensitivity was assessed from phase plots and high potassium contractures of force against [Ca2+ ]i . Trabeculae from diabetic patients (n = 12) had increased diastolic (resting) [Ca2+ ]i (p = 0.03) and reduced Ca2+ transient amplitude (p = 0.04) when compared to non-diabetic patients (n = 11), with no difference in the Ca2+ transient time course. Diastolic stress was increased (p = 0.008) in trabeculae from diabetic patients, and peak developed stress decreased (p ≤ 0.001), which were not accounted for by reduction in the cardiomyocyte, or contractile protein, content of trabeculae. Trabeculae from diabetic patients also displayed diminished myofilament Ca2+ sensitivity (p = 0.018) compared to non-diabetic patients. Our data provides evidence of impaired calcium handling during excitation-contraction coupling with resulting contractile dysfunction in atrial tissue from patients with type 2 diabetes in comparison to the non-diabetic. This highlights the importance of targeting cardiomyocyte Ca2+ homeostasis in developing more effective treatment options for diabetic heart disease in the future.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Antihypertensive Drugs: Action of Calcium Channel Blockers

